Clinical Trial Update: This Clinical Trial is a Retrospective, Multicenter Cohort Study Evaluating the Real-world Characteristics and Risk of Disease Recurrence in Hormone Receptor-positive, HER2-negative Early Breast Cancer.

View source ↗

Summary

A retrospective, multicenter cohort study evaluating real-world characteristics and recurrence risk in hormone receptor-positive, HER2-negative early breast can…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Samsung Medical Center | Conditions: Early Breast Cancer | Status: NOT_YET_RECRUITING